Oberweis Asset Management Inc Halozyme Therapeutics, Inc. Transaction History

Oberweis Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $1.53 Million - $1.93 Million	45,800 Added 90.69%	96,300 $3.56 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $1.84 Million - $2.22 Million	50,500 New	50,500 $1.93 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $678,559 - $1.15 Million	20,650 Added 14.4%	164,040 $6.26 Million
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $1.08 Million - $1.6 Million	26,850 Added 23.04%	143,390 $8.16 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $519,769 - $698,512	13,490 Added 13.09%	116,540 $4.61 Million
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $164,340 - $212,520	-4,400 Reduced 4.09%	103,050 $4.53 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $57,546 - $73,908	1,800 Added 1.7%	107,450 $4.29 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $1.14 Million - $1.45 Million	35,670 Added 50.97%	105,650 $4.25 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $30,006 - $36,207	780 Added 1.13%	69,980 $2.85 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $11,652 - $15,393	300 Added 0.44%	69,200 $3.14 Million
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $2.72 Million - $3.54 Million	68,900 New	68,900 $2.87 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oberweis Asset Management Inc with notifications on news.